Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Fuji
US Department of Justice
Deloitte
Mallinckrodt
Chubb
Queensland Health
McKinsey
QuintilesIMS
Merck

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,770,619

« Back to Dashboard

Summary for Patent: 5,770,619
Title: Method of activating photosensitive agents
Abstract:A method of administering photodynamic therapy begins with administering to an animal an effective amount of a photosensitizing agent which is less than about one half of the usual clinical dose for the photosensitizing agent. Then, following a post injection interval which is less about one quarter of the usual post injection interval, an effective dose of light which is less than about one half of the usual clinical dose of light used in conjunction with the photosensitizing agent is administered to the animal.
Inventor(s): Richter; Anna M. (Vancouver, CA), Waterfield; Elizabeth (Vancouver, CA), Levy; Julia G. (Vancouver, CA)
Assignee: University of British Columbia (Vancouver, CA)
Application Number:08/551,471
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,770,619

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,770,619

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain 2148132 ➤ Subscribe
Spain 2143539 ➤ Subscribe
Germany 947222 ➤ Subscribe
Germany 69327972 ➤ Subscribe
Germany 69334009 ➤ Subscribe
Denmark 0680365 ➤ Subscribe
Denmark 0947222 ➤ Subscribe
European Patent Office 0680365 ➤ Subscribe
European Patent Office 0947222 ➤ Subscribe
Canada 2149636 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Citi
US Army
McKesson
Harvard Business School
Moodys
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot